Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1

Conditions

Thyroid Neoplasms 1Stress Disorders, Post-Traumatic 1Neoplasms 1Melanoma, Cutaneous Malignant 1Anxiety Disorders 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER × Eye Movement Desensitization Reprocessing × Clear all
NCT07447089 2026-03-04

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

Università Cattolica di Milano

Phase NA Recruiting
25 enrolled
Head & Neck

Neoplasms, Stress Disorders, Post-Traumatic, Thyroid Neoplasms

NCT06767332 2025-01-09

FAME

Leiden University Medical Center

Phase NA Recruiting
30 enrolled
Dermatologic

Melanoma, Cutaneous Malignant, Anxiety Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡